Eslami, S. M. (2017) “Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials”, Journal of Pharmacy & Pharmaceutical Sciences, 20, pp. 81–96. doi: 10.18433/J36C8N.